Clinical Trial Update: Orca-T Expanded Access Program Study for Patients With Advanced Hematologic Malignancies

View source ↗

Summary

The Orca-T Expanded Access Program study for patients with advanced hematologic malignancies has a status update. The study is temporarily not available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Mixed Phenotype Acute Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Orca-T

Snippet

Sponsor: Orca Biosystems, Inc. | Conditions: Hematologic Malignancies, Acute Myeloid Leukemia | Status: TEMPORARILY_NOT_AVAILABLE